TELA Bio
TELA
49 hedge funds and large institutions have $45.6M invested in TELA Bio in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 22 reducing their positions, and 27 closing their positions.
7.72% less ownership
Funds ownership: 80.61% → 72.89% (-7.7%)
28% less funds holding
Funds holding: 68 → 49 (-19)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
50% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 22
51% less capital invested
Capital invested by funds: $93.4M → $45.6M (-$47.8M)
70% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 27
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$2.89M |
| 2 |
Citigroup
New York
|
+$2.66M |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$1.72M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$681K |
| 5 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
+$509K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
-$5.9M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$3.35M |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$1.89M |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$1.8M |
| 5 |
O
OrbiMed
New York
|
-$1.05M |
TELA Hedge Fund Activity: Q3 2024 in Review
49 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q3 2024, worth a combined $45.6M — down 51% from $93.4M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of TELA and 8 opened new positions — a net loss of 19 holders — while 22 trimmed existing stakes and 11 added.
The largest buyer was AIGH Capital Management, adding an estimated $2.89M. The largest seller was Paradigm Capital Management Inc, exiting entirely with an estimated $5.9M sold.
- 49 institutional investors held TELA Bio (TELA) as of Q3 2024, down from 68 in Q2 2024.
- Funds reported $45.6M of TELA Bio stock for Q3 2024, down 51% quarter-over-quarter.
- 8 funds opened new TELA Bio positions in Q3 2024 and 27 closed out, a net change of -19 holders.
- The largest TELA Bio buyer in Q3 2024 was AIGH Capital Management, an estimated $2.89M added.
- The largest TELA Bio seller in Q3 2024 was Paradigm Capital Management Inc, an estimated $5.9M sold.
Based on aggregated 13F filings for Q3 2024.